Moraxella catarrhalis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 25: | Line 25: | ||
[[Category:Human pathogens]] | [[Category:Human pathogens]] | ||
{{Bacteria-stub}} | {{Bacteria-stub}} | ||
<gallery> | |||
File:Moraxella_Catarrhalis.png|Moraxella catarrhalis | |||
File:M._cat_BSAC.JPG|Moraxella catarrhalis on blood agar | |||
File:Hockey_Puck_Test_Graphic.png|Hockey puck test for Moraxella catarrhalis | |||
</gallery> | |||
Latest revision as of 01:10, 18 February 2025
Moraxella catarrhalis is a Gram-negative, aerobic, oxidase-positive diplococcus bacterium that is frequently found in the human respiratory tract. It is a significant human pathogen that causes infections primarily in the upper respiratory tract and the middle ear.
Classification[edit]
Moraxella catarrhalis belongs to the Moraxellaceae family of the Gammaproteobacteria class. It was previously known as Micrococcus catarrhalis and Neisseria catarrhalis before being classified under the Moraxella genus.
Pathogenesis[edit]
Moraxella catarrhalis is a common cause of otitis media in children and respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD). It has also been associated with bacteremia, meningitis, endocarditis, and septic arthritis in rare cases.
Treatment[edit]
The treatment of Moraxella catarrhalis infections typically involves antibiotics. The bacterium is generally susceptible to amoxicillin-clavulanate, cefuroxime, and macrolide antibiotics. However, resistance to penicillin and ampicillin has been reported.
Epidemiology[edit]
Moraxella catarrhalis is a common inhabitant of the human upper respiratory tract. It is found in approximately 3% of adults and up to 15% of children. The bacterium is spread through respiratory droplets.
See also[edit]
References[edit]
<references />
-
Moraxella catarrhalis
-
Moraxella catarrhalis on blood agar
-
Hockey puck test for Moraxella catarrhalis
